Your browser doesn't support javascript.
loading
Endocytic degradation of ErbB2 mediates the effectiveness of neratinib in the suppression of ErbB2-positive ovarian cancer.
Wang, Shanshan; Zhang, Jinrui; Wang, Taishu; Ren, Feng; Liu, Xiuxiu; Lu, Yongqi; Xu, Linying; Zhang, Yang; Wang, Duchuang; Xu, Lu; Wu, Yueguang; Liu, Fang; Li, Qiong; Zaky, Mohamed Y; Liu, Shuyan; Dong, Weijie; Liu, Fang; Zou, Kun; Zhang, Yingqiu.
Afiliación
  • Wang S; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang J; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wang T; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Ren F; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liu X; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Lu Y; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Xu L; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang Y; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wang D; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Xu L; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wu Y; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liu F; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Li Q; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zaky MY; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China; Molecular Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, Egypt.
  • Liu S; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Dong W; College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
  • Liu F; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China; Department of Oncology, Second Affiliated Hospital, Dalian Medical University, Dalian, China. Electronic address: liufang_dy@sina.com.
  • Zou K; Department of Radiotherapy Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address: zoukun29@163.com.
  • Zhang Y; The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. Electronic address: zhangyingqiu.no.1@163.com.
Int J Biochem Cell Biol ; 117: 105640, 2019 12.
Article en En | MEDLINE | ID: mdl-31689531
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Quinolinas / Receptor ErbB-2 Límite: Animals / Female / Humans Idioma: En Revista: Int J Biochem Cell Biol Asunto de la revista: BIOQUIMICA Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Quinolinas / Receptor ErbB-2 Límite: Animals / Female / Humans Idioma: En Revista: Int J Biochem Cell Biol Asunto de la revista: BIOQUIMICA Año: 2019 Tipo del documento: Article País de afiliación: China